Intradialytic Hypertension in Hemodialysis PatientsNCT07069491
Search About Contributing Factors That Leading to Intradialytic Hypertension in Hemodialysis Patients
An observational study of Intradialytic Hypertension in Hemodialysis Patients, run by Sohag University at 1 site in Egypt.
Trial summary
The aim of this study is searching about contributing factors that leading to intradialytic hypertension in hemodialysis patients more than 18 years old in hemodialysis unit at sohag University hospitals Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Intradialytic Hypertension in Hemodialysis Patients
- What is being tested?
- Sphygmomanometer
- Type of treatment
- Medical device
- How many people
- 50 participants
- Where
- 1 siteEgypt
- Study dates
- 28 Jun 2025to 1 Nov 2025
- How long will I take part?
- 3 Months
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Hemodialysis patients
Who may be able to join
- All patients aged 18 year or older, on maintenance hemodialysis for at least three consecutive, receiving 3 sessions weekly, 4 hours in each session
Who cannot join
- patients aged less than 18 years old Patients on recent hemodialysis less than 3 months Patients with malignancy, severe infection or sepsis Patients with major bleeding
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Faculty of medicine sohag University, sohag Recruiting
Sohag
Aya Ali Amin, 01022986744 ext. 01273794028, ayah.ali@med.sohag.edu.eg
Aya Ali Amin
About this study
Official title: Study of Contributing Factors of Intradialytic Hypertension In Hemodialysis Patients at Sohag University Hospitals
The aim of this study is searching about contributing factors that leading to intradialytic hypertension in hemodialysis patients more than 18 years old in hemodialysis unit at sohag University hospitals
Read the detailed description
Study of Contributing Factors of Intradialytic Hypertension in Hemodialysis patients aged more than 18 years old on regular dialysis session for more than 3 months, receiving dialysis session 3 time weekly for 4 hours,blood pressure monitoring for everyone pre and in and post the sessions and records also investigations will be taken before hemodialysis sessions and full medical history will be collected
- Being tested
- Sphygmomanometer
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SphygmomanometerDevice
Blood pressure measurement by Sphygmomanometer
What is being measured
The primary outcome is the main question the study is designed to answer.
Study the contributing factors of intradialytic hypertension in hemodialysis patients
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jul 2025
- Study start28 Jun 2025
- Primary completion1 Sep 2025 (estimated)
- Study completion1 Nov 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Intradialytic Hypertension in Hemodialysis PatientsStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
- Target duration
- 3 Months
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aya Ali Amin, Sohag University
- Investigators
- Aya Ali Amin, Study chair, Sohag University hospitals
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07069491
- Sponsor's protocol ID
- Soh-Med--25-6-3MS
- Status last verified
- Jun 2025
- First submitted
- 4 Jul 2025
- Last updated
- 16 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 16 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study of Contributing Factors of Intradialytic Hypertension In Hemodialysis Patients at Sohag University Hospitals
- ClinicalTrials.gov ID
- NCT07069491
- Acronym / sponsor ID
- Soh-Med--25-6-3MS
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 28 Jun 2025 (actual)
- Primary completion
- 1 Sep 2025 (estimated)
- Study completion
- 1 Nov 2025 (estimated)
- First posted
- 16 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is searching about contributing factors that leading to intradialytic hypertension in hemodialysis patients more than 18 years old in hemodialysis unit at sohag University hospitals
Detailed description
Study of Contributing Factors of Intradialytic Hypertension in Hemodialysis patients aged more than 18 years old on regular dialysis session for more than 3 months, receiving dialysis session 3 time weekly for 4 hours,blood pressure monitoring for everyone pre and in and post the sessions and records also investigations will be taken before hemodialysis sessions and full medical history will be collected
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Target follow-up
- 3 Months
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Hemodialysis patients
Key inclusion criteria (1 listed)
- All patients aged 18 year or older, on maintenance hemodialysis for at least three consecutive, receiving 3 sessions weekly, 4 hours in each session
Key exclusion criteria (1 listed)
- patients aged less than 18 years old Patients on recent hemodialysis less than 3 months Patients with malignancy, severe infection or sepsis Patients with major bleeding
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SphygmomanometerBlood pressure measurement by Sphygmomanometer | Device | – |
Primary outcome
Study the contributing factors of intradialytic hypertension in hemodialysis patients
Time frame: Baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jul 2025.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Aya Ali Amin study chair
Sohag University hospitals
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Intradialytic Hypertension in Hemodialysis Patients, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Aya Ali Amin (01022986744, ayah.ali@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Study the contributing factors of intradialytic hypertension in hemodialysis patients (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2025.